切除不能肝細胞癌患者の実臨床における全生存率

基本情報

NCT ID: NCT03612726
ステータス: 募集中
試験のフェーズ: -
試験タイプ: 観察
目標被験者数: 5,000
治験依頼者名: Humanity & Health Medical Group Limited

概要

Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The pattern of HCC occurrence shows a significant geographical imbalance, with the highest incidence rates in East Asia (more than 50% of the cases occurring in China). The aim of this study is to investigate the overall survival (OS) of patients diagnosed with unresectable hepatocellular carcinoma under real-world practice conditions in Asia Pacific region.

対象疾患

Hepatocellular Carcinoma

依頼者（Sponsor）

Humanity & Health Medical Group Limited(OTHER)

Tokyo University(OTHER)

実施施設 (1)

Tokyo University

Tokyo, Japan(RECRUITING)